Client
- Name
- BIOGEN
- Location
- District of Columbia · United States of America
Registrant
- Firm
- BIOGEN
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
7 issuesHealth Issues
Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, screening and diagnosis, PET scan coverage and reimbursement, and dementia care Inflation Reduction Act implementation, including provisions related to corporate taxes, Medicare, and prescription drug pricing Mental Health Workforce Expansion The Mental Health Professionals Workforce Shortage Loan Repayment Act HELP Copays Act Issues related to ALS
LobbyistsJOHN RAYMOND GIBSON · JONATHAN CAUSEY · TYLER HANSON · DANIEL HARDER · mx ALI LAKHANI · ms KATHLEEN KONKA
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Medicare/Medicaid
Drug cost and pricing policy issues Issues regarding coverage, coding, and reimbursement issues Issues regarding Alzheimer's treatments Issues related to the 340B program
LobbyistsDANIEL HARDER · ms KATHLEEN KONKA
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Pharmacy
Drug cost and pricing policy S.127, Pharmacy Benefit Manager Transparency Act and other PBM reforms Discussions regarding pharmaceutical issues related to supply chain